ArticleNature communications2022
Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer.
Edward M Kennedy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it